Physician profile
Nancy Xia
NPI 1659875656
$2,097.52
in general payments reported to CMS, 2019-2025
8 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,671 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Travel and Lodging: $500 · Gift: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.52 |
| Travel and Lodging | $500.00 |
| Gift | $100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuropace, INC. | $500.78 | 2024-2025 | |
| Ceribell, INC. | $500.00 | 2024 | Pocket Eeg Device |
| Jazz Pharmaceuticals INC. | $360.89 | 2024-2025 | Epidiolex |
| Ucb, INC. | $258.30 | 2024-2025 | Fintepla |
| Sk Life Science, INC. | $237.22 | 2024-2025 | Xcopri |
| Neurelis, INC. | $140.33 | 2024 | Valtoco |
| J2 Bio-Pharma LLC | $100.00 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Xia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.